Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mel Greaves

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Leukemia|December 19, 2022
Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute lymphoblastic leukaemiaAnthony M Ford, Susan Colman, Mel Greaves
International Journal of Hematology|January 6, 2004
The role of the MLL gene in infant leukemiaMariko Eguchi, Minenori Eguchi-Ishimae, Mel Greaves
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2004
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in miceShinobu Tsuzuki, Masao Seto, Mel Greaves, et al.
Blood|September 29, 2007
NOTCH1 mutation can be an early, prenatal genetic event in T-ALLMinenori Eguchi-Ishimae, Mariko Eguchi, Helena Kempski, et al.
Experimental Hematology|August 8, 2007
Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesisClara Bueno, Luiz F Lopes, Mel Greaves, et al.
Plos One|May 20, 2025
Microbiome and pediatric leukemia, diabetes, and allergies: Systematic review and meta-analysisRachel Gallant, Samiha Reza, Joseph L Wiemels, et al.
Blood|January 8, 2011
Fusion genes in cord bloodMel Greaves, Susan M Colman, Lyndal Kearney, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2005
Directing oncogenic fusion genes into stem cells via an SCL enhancerMariko Eguchi, Minenori Eguchi-Ishimae, Anthony Green, et al.
Blood|September 9, 2011
ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptorVeronica Torrano, Julia Procter, Penny Cardus, et al.
Genes, Chromosomes & Cancer|May 12, 2006
MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemiaMariko Eguchi, Minenori Eguchi-Ishimae, Deborah Knight, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Leukemia|December 19, 2022
Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute lymphoblastic leukaemiaAnthony M Ford, Susan Colman, Mel Greaves
International Journal of Hematology|January 6, 2004
The role of the MLL gene in infant leukemiaMariko Eguchi, Minenori Eguchi-Ishimae, Mel Greaves
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2004
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in miceShinobu Tsuzuki, Masao Seto, Mel Greaves, et al.
Blood|September 29, 2007
NOTCH1 mutation can be an early, prenatal genetic event in T-ALLMinenori Eguchi-Ishimae, Mariko Eguchi, Helena Kempski, et al.
Experimental Hematology|August 8, 2007
Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesisClara Bueno, Luiz F Lopes, Mel Greaves, et al.
Plos One|May 20, 2025
Microbiome and pediatric leukemia, diabetes, and allergies: Systematic review and meta-analysisRachel Gallant, Samiha Reza, Joseph L Wiemels, et al.
Blood|January 8, 2011
Fusion genes in cord bloodMel Greaves, Susan M Colman, Lyndal Kearney, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2005
Directing oncogenic fusion genes into stem cells via an SCL enhancerMariko Eguchi, Minenori Eguchi-Ishimae, Anthony Green, et al.
Blood|September 9, 2011
ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptorVeronica Torrano, Julia Procter, Penny Cardus, et al.
Genes, Chromosomes & Cancer|May 12, 2006
MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemiaMariko Eguchi, Minenori Eguchi-Ishimae, Deborah Knight, et al.
Pageof 11